Swisscanto Holding

ANYbotics AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing autonomous, legged robots designed for industrial applications. The company focuses on creating innovative robotic solutions that enhance worker safety and productivity while promoting sustainable industrial practices. ANYbotics' robots are equipped with advanced features such as docking stations, sensing capabilities, and waterproof designs, enabling them to perform various tasks, including routine inspections, asset monitoring, gas detection, and the creation of 3D models. Their technology is particularly beneficial for industries like oil and gas, power, energy, mining, processing, chemicals, transportation, and construction, where complex and hazardous environments require reliable inspection solutions. With a team of over 100 employees, ANYbotics collaborates with global technology leaders to deliver integrated robotic systems that support the operational needs of large asset operators.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.

ANYbotics AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing autonomous, legged robots designed for industrial applications. The company focuses on creating innovative robotic solutions that enhance worker safety and productivity while promoting sustainable industrial practices. ANYbotics' robots are equipped with advanced features such as docking stations, sensing capabilities, and waterproof designs, enabling them to perform various tasks, including routine inspections, asset monitoring, gas detection, and the creation of 3D models. Their technology is particularly beneficial for industries like oil and gas, power, energy, mining, processing, chemicals, transportation, and construction, where complex and hazardous environments require reliable inspection solutions. With a team of over 100 employees, ANYbotics collaborates with global technology leaders to deliver integrated robotic systems that support the operational needs of large asset operators.

EcoRobotix Ltd is a Swiss company founded in 2011, specializing in the development and manufacturing of autonomous farming machines aimed at enhancing agricultural efficiency and sustainability. The company offers an advanced robotic solution designed for the weeding of row crops, meadows, and intercropping cultures. Its flagship product features a sophisticated plant recognition system, utilizing a combination of cameras, GPS RTK, and sensors to accurately identify and locate weeds. This technology allows the robot to apply herbicides with ultra-high precision, significantly reducing chemical usage by 70-95%, which not only lowers costs for farmers but also lessens the environmental impact of conventional farming practices. By improving crop yields while minimizing resource consumption, EcoRobotix positions itself as a key player in promoting sustainable agriculture.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Sulzer Schmid is an independent Swiss technology company specializing in advanced solutions for the inspection and analysis of rotor blades. The company has developed a cloud-based platform that provides comprehensive inspection tools and data analytics, enabling windmill operators to monitor the health status of their rotor blades. This platform offers a transparent view of blade conditions across an entire fleet, allowing customers to capture visual data, process images, and generate customizable reports. Through its innovative technology, Sulzer Schmid empowers operators to track damage progression over time, facilitating informed decision-making regarding maintenance and repairs.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.

SWISSto12 SA is a Swiss company that specializes in the manufacture and supply of radio frequency (RF) and microwave components and systems. Founded in 2011 as a spin-off from the Swiss Federal Institute of Technology in Lausanne, the company is based in Renens, Switzerland, with additional offices in Santa Clara, California, and Rehovot, Israel. SWISSto12 offers a range of products including various types of horn antennas, airborne antenna arrays, waveguide antennas, and custom-designed antennas and filters. The company is known for its innovative use of metal-coated 3D printing technology, which enhances design flexibility while reducing costs, lead times, and weight. Its offerings extend to polymer and metal waveguide products, as well as integration and testing services. SWISSto12 serves clients in satellite communications, airborne satellites, and research centers, and is also developing software solutions for material properties extraction.